JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

B5904 Regadenoson
1 Citation

Target: Adenosine A2A Receptors

Summary: Highly selective and low affinity A2A adenosine agonist

insoluble in H2O; insoluble in EtOH; ≥18.05 mg/mL
B5960 PF-03394197(Oclacitinib)

Summary: Novel Janus kinase inhibitor

≥33.7 mg/mL
B5970 Sanguinarine chloride

Summary: Inhibitor of PP2C and MKP-1

insoluble in H2O; insoluble in EtOH; ≥3.68 mg/mL
A1045 Gap 27
9 Citation

Target: Gap Junctions

Summary: Selective gap junction blocker

insoluble in EtOH; ≥5 mg/mL
A4145 TG101209

Summary: JAK2/3 inhibitor

≥25.5 mg/mL
A4529 JW 55

Summary: PARP domain inhibitor

insoluble in H2O; ≥19.25 mg/mL
A4453 NSC 687852 (b-AP15)

Target: Deubiquitinating enzymes (DUBs)

Summary: 19S regulatory particle Inhibitor

insoluble in EtOH; insoluble in H2O; ≥20.95 mg/mL
A4484 PRIMA-1MET

Summary: Restore mutant p53 activity, induce BAX and PUMA
A3963 A-769662
4 Citation

Summary: AMPK activator,potent and reversible

insoluble in EtOH; insoluble in H2O; ≥18.02 mg/mL
A5057 MGCD-265

Target: VEGFR|c-MET

Summary: Met/Flt/Flk/Ron/Tie-2 inhibitor

≥25.9 mg/mL